Target intelligence / Profile preview

AU-rich element-containing messenger RNA

Molecular classification
Other (regulatory RNA feature), Not a protein, enzyme, transporter, or receptor
01

Overview

AU-rich element-containing messenger RNAs harbor **adenylate-uridylate-rich elements (AREs)** within their 3′ untranslated regions, which confer regulatory properties by promoting rapid turnover or modulating translation of the mRNA[4][1][5][6][7]. These elements recruit RNA-binding proteins—such as AUF1, tristetraprolin (TTP), and Hu antigen R (HuR)—that can either destabilize and degrade the mRNA or stabilize it and enhance its translation[4][3][6][7]. Many genes critical for cell growth, immune responses, inflammation, and stress responses are regulated post-transcriptionally via these AREs[5][6][7]. Misregulation of ARE-containing mRNAs is implicated in diseases such as cancer, chronic inflammation, and cardiovascular and autoimmune conditions[6][4]. While not a direct therapeutic target, the ARE regulatory system is an important focus for drug development that aims to modulate the stability of disease-related transcripts by targeting their binding proteins. "AU-rich element-containing mRNA" is a descriptive class of mRNAs regulated via short AU-rich sequences in their 3′ UTR that dictate their stability and translation through interaction with RNA-binding proteins, playing essential roles in many physiological and pathological processes[4][1][5][6][7]. It is not itself a canonical molecular target for drugs.

Other names
AU-rich mRNAARE-containing mRNAadenylate-uridylate-rich element-containing mRNA
02

Biological functions

Regulation of mRNA stabilityRegulation of gene expressionControl of mRNA translationRapid mRNA decay
03

Disease associations

CancerInflammationCardiovascular diseaseImmune responseOther (general regulation implicated in many diseases when dysregulated)

Beyond the preview

Go deeper on AU-rich element-containing messenger RNA.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on AU-rich element-containing messenger RNA.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call